263 is the total number of securities Avoro Capital Advisors LLC has owned. The longest Avoro Capital Advisors LLC has owned a single stock is 36 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| FOLD | AMICUS THERAPEUTICS INC | 36 | 36 | 2.09% | 6.25% | 17.89% | Q4 2014 | Q3 2023 | 36 |
| MRTX | MIRATI THERAPEUTICS INC. | 35 | 35 | 1.05% | 8.43% | 17.15% | Q1 2015 | Q3 2023 | 35 |
| BMRN | BIOMARIN PHARMACEUTICA... | 31 | 31 | 1.89% | 5.23% | 7.98% | Q1 2016 | Q3 2023 | 31 |
| SRPT | SAREPTA THERAPUTICS INC | 22 | 6 | 2.77% | 6.01% | 14.76% | Q3 2015 | Q3 2023 | 28 |
| ASND | ASCENDIS PHARMA | 18 | 10 | 0.16% | 5.19% | 9.14% | Q3 2016 | Q3 2023 | 28 |
| ARGX | ARGENX SE | 26 | 26 | 0.58% | 4.79% | 9.48% | Q2 2017 | Q3 2023 | 26 |
| IOVA | IOVANCE BIOTHERAPEUTIC... | 26 | 26 | 0.48% | 4.11% | 9.11% | Q2 2017 | Q3 2023 | 26 |
| FENC | FENNEC PHARMACEUTICALS... | 25 | 25 | 0.06% | 0.20% | 0.42% | Q3 2017 | Q3 2023 | 25 |
| MDGL | MADRIGAL PHARMACEUTICA... | 22 | 22 | 0.78% | 2.69% | 7.20% | Q2 2018 | Q3 2023 | 22 |
| XENE | XENON PHARMACEUTICALS INC | 22 | 22 | 0.43% | 1.59% | 3.27% | Q2 2018 | Q3 2023 | 22 |
| CBAY | CYMABAY THERAPEUTICS INC | 19 | 1 | 0.28% | 0.81% | 2.40% | Q2 2018 | Q3 2023 | 20 |
| IMMU | IMMUNOMEDICS INC | 19 | 19 | 0.92% | 12.76% | 31.71% | Q1 2016 | Q3 2020 | 19 |
| ACAD | ACADIA PHARMACEUTICALS... | 6 | 1 | 0.10% | 2.45% | 8.66% | Q2 2015 | Q1 2022 | 19 |
| HZNP | HORIZON THERAPEUTICS PLC | 18 | 18 | 3.33% | 9.80% | 17.05% | Q2 2019 | Q3 2023 | 18 |
| AMRN | AMARIN CORP PLC | 17 | 17 | 0.12% | 1.78% | 7.18% | Q3 2018 | Q3 2022 | 17 |
| TLGT | TELIGENT INC. | 16 | 16 | 0.11% | 1.74% | 4.77% | Q4 2015 | Q3 2019 | 16 |
| TRILLIUM THERAPEUTICS INC | 9 | 7 | 0.18% | 0.86% | 1.57% | Q1 2015 | Q3 2021 | 16 | |
| AGEN | AGENUS INC | 14 | 1 | 0.16% | 2.76% | 7.10% | Q4 2014 | Q1 2020 | 15 |
| GBT | GLOBAL BLOOD THERAPEUT... | 15 | 15 | 0.50% | 2.53% | 4.70% | Q1 2016 | Q3 2019 | 15 |
| ALIM | ALIMERA SCIENCES INC | 13 | 2 | 0.15% | 0.62% | 2.30% | Q4 2014 | Q3 2019 | 15 |
| VNDA | VANDA PHARMACEUTICALS INC | 14 | 14 | 0.45% | 2.40% | 6.23% | Q2 2015 | Q3 2018 | 14 |
| KURA | KURA ONCOLOGY INC | 14 | 14 | 0.34% | 1.09% | 2.25% | Q2 2020 | Q3 2023 | 14 |
| RNA | AVIDITY BIOSCIENCES INC | 14 | 14 | 0.20% | 0.38% | 0.68% | Q2 2020 | Q3 2023 | 14 |
| APLS | APELLIS PHARMACEUTICAL... | 11 | 2 | 0.36% | 6.30% | 13.73% | Q4 2017 | Q3 2023 | 13 |
| ZGNX | ZOGENIX INC | 13 | 13 | 0.22% | 2.80% | 4.56% | Q3 2017 | Q3 2020 | 13 |
| ISEE | IVERIC BIO INC | 13 | 13 | 0.58% | 1.69% | 4.30% | Q2 2020 | Q2 2023 | 13 |
| MRSN | MERSANA THERAPEUTICS INC | 13 | 13 | 0.28% | 1.28% | 3.12% | Q2 2020 | Q2 2023 | 13 |
| BCRX | BIOCRYST PHARMACEUTICL... | 7 | 6 | 0.11% | 1.26% | 2.11% | Q3 2016 | Q3 2023 | 13 |
| PMVP | PMV PHARMACEUTICALS INC | 13 | 13 | 0.22% | 0.84% | 2.25% | Q3 2020 | Q3 2023 | 13 |
| UTHR | UNITED THERAPEUTICS CORP | 12 | 12 | 7.45% | 10.05% | 13.83% | Q4 2020 | Q3 2023 | 12 |
| DERM | DERMIRA INC | 12 | 12 | 0.65% | 3.32% | 5.24% | Q3 2015 | Q2 2018 | 12 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 12 | 12 | 0.32% | 1.56% | 3.13% | Q2 2016 | Q1 2019 | 12 |
| ADVM | ADVERUM BIOTECHNOLOGIE... | 12 | 12 | 0.17% | 1.23% | 3.13% | Q2 2019 | Q1 2022 | 12 |
| VCYT | VERACYTE INC | 12 | 12 | 0.03% | 1.10% | 2.33% | Q2 2015 | Q1 2018 | 12 |
| SNDX | SYNDAX PHARMACEUTICALS... | 12 | 12 | 0.17% | 0.75% | 1.01% | Q4 2020 | Q3 2023 | 12 |
| BDSI | BIODELIVERY SCIENCES I... | 11 | 1 | 0.18% | 0.75% | 1.70% | Q4 2016 | Q2 2020 | 12 |
| MNKD | MANNKIND CORP | 12 | 12 | 0.19% | 0.58% | 0.82% | Q4 2020 | Q3 2023 | 12 |
| MARINUS PHARMACEUTICAL... | 12 | 12 | 0.19% | 0.53% | 1.01% | Q4 2020 | Q3 2023 | 12 | |
| CLLS | CELLECTIS S A | 12 | 12 | 0.15% | 0.27% | 0.40% | Q1 2015 | Q4 2017 | 12 |
| SRNE | SORRENTO THERAPEUTICS INC | 11 | 11 | 0.10% | 3.93% | 10.61% | Q4 2014 | Q2 2017 | 11 |
| ALNY | ALNYLAM PHARMACEUTICAL... | 10 | 1 | 2.52% | 3.27% | 4.09% | Q2 2018 | Q3 2023 | 11 |
| PCRX | PACIRA PHARMACEUTICALS... | 11 | 11 | 0.60% | 1.97% | 3.82% | Q1 2017 | Q3 2019 | 11 |
| PERNIX THERAPEUTICS HO... | 11 | 11 | 0.10% | 0.21% | 0.36% | Q2 2016 | Q4 2018 | 11 | |
| KYMR | KYMERA THERAPEUTICS INC | 9 | 1 | 0.02% | 0.82% | 1.69% | Q3 2020 | Q3 2023 | 10 |
| GLUE | MONTE ROSA THERAPEUTIC... | 10 | 10 | 0.34% | 0.69% | 1.15% | Q2 2021 | Q3 2023 | 10 |
| DSGN | DESIGN THERAPEUTICS INC | 10 | 10 | 0.30% | 0.50% | 0.69% | Q1 2021 | Q2 2023 | 10 |
| ONS | ONCOBIOLOGICS INC | 10 | 10 | 0.02% | 0.16% | 0.42% | Q2 2016 | Q3 2018 | 10 |
| ONSIW | ONCOBIOLOGICS INC - WA... | 10 | 10 | 0.00% | 0.01% | 0.02% | Q2 2016 | Q3 2018 | 10 |
| LBIO | LION BIOTECHNOLOGIES INC | 9 | 9 | 4.33% | 6.75% | 9.99% | Q1 2015 | Q1 2017 | 9 |
| MDCO | MEDICINES CO | 6 | 3 | 0.78% | 3.08% | 7.40% | Q1 2017 | Q3 2019 | 9 |
| NEURODERM LTD. | 9 | 9 | 0.17% | 2.70% | 5.93% | Q2 2015 | Q2 2017 | 9 | |
| MYOK | MYOKARDIA INC | 7 | 2 | 1.09% | 2.58% | 3.65% | Q3 2017 | Q3 2020 | 9 |
| TCDA | TRICIDA INC | 9 | 9 | 0.33% | 2.00% | 3.00% | Q2 2018 | Q2 2020 | 9 |
| FBIO | FORTRESS BIOTECH INC. | 9 | 9 | 0.36% | 0.83% | 1.45% | Q2 2015 | Q2 2017 | 9 |
| CPRX | CATALYST PHARMACEUTICA... | 8 | 1 | 0.24% | 0.82% | 1.33% | Q4 2014 | Q3 2018 | 9 |
| AADI BIOSCIENCES INC | 9 | 9 | 0.22% | 0.52% | 0.84% | Q3 2021 | Q3 2023 | 9 | |
| AVDL | AVADEL PHARMACEUTICALS... | 9 | 9 | 0.21% | 0.52% | 1.17% | Q1 2020 | Q1 2022 | 9 |
| NUVALENT INC | 9 | 9 | 0.27% | 0.50% | 0.92% | Q3 2021 | Q3 2023 | 9 | |
| SRPT | SAREPTA THERAPUTICS INC | 5 | 1 | 0.03% | 0.36% | 1.06% | Q3 2015 | Q1 2023 | 9 |
| TANGO THERAPEUTICS INC | 9 | 9 | 0.07% | 0.20% | 0.39% | Q3 2021 | Q3 2023 | 9 | |
| TSRO | TESARO INC. | 7 | 1 | 0.27% | 5.06% | 9.60% | Q1 2016 | Q3 2018 | 8 |
| ARRY | ARRAY BIOPHARMA INC | 6 | 2 | 0.28% | 3.18% | 5.11% | Q4 2016 | Q2 2019 | 8 |
| KRYS | KRYSTAL BIOTECH INC | 8 | 8 | 0.56% | 2.16% | 4.64% | Q4 2021 | Q3 2023 | 8 |
| DCPH | DECIPHERA PHARMACEUTIC... | 8 | 8 | 0.57% | 1.30% | 2.78% | Q4 2019 | Q3 2021 | 8 |
| PTCT | PTC THERAPEUTICS INC | 3 | 1 | 0.28% | 1.21% | 2.98% | Q2 2017 | Q2 2020 | 8 |
| VCEL | VERICEL CORP. | 8 | 8 | 0.11% | 0.92% | 2.18% | Q4 2014 | Q3 2016 | 8 |
| INTEC PHARMA LTD | 8 | 8 | 0.12% | 0.76% | 1.52% | Q3 2017 | Q2 2019 | 8 | |
| DICE THERAPEUTICS INC | 8 | 8 | 0.24% | 0.75% | 1.68% | Q3 2021 | Q2 2023 | 8 | |
| GNCA | GENOCEA BIOSCIENCES INC | 8 | 8 | 0.00% | 0.15% | 0.24% | Q3 2020 | Q2 2022 | 8 |
| IO BIOTECH INC | 8 | 8 | 0.04% | 0.11% | 0.19% | Q4 2021 | Q3 2023 | 8 | |
| ONSIZ | ONCOBIOLOGICS INC - WA... | 8 | 8 | 0.00% | 0.02% | 0.04% | Q2 2016 | Q1 2018 | 8 |
| XLRN | ACCELERON PHARMA INC | 7 | 7 | 1.96% | 4.93% | 10.81% | Q1 2020 | Q3 2021 | 7 |
| SGEN | SEAGEN INC | 7 | 7 | 3.46% | 4.71% | 5.82% | Q1 2022 | Q3 2023 | 7 |
| HZNP | HORIZON PHARMA PLC | 7 | 7 | 3.46% | 4.05% | 5.08% | Q3 2017 | Q1 2019 | 7 |
| LJPC | LA JOLLA PHARMACEUTICA... | 7 | 7 | 0.25% | 3.62% | 7.29% | Q4 2014 | Q2 2016 | 7 |
| ARNA | ARENA PHARMACEUTICALS INC | 7 | 7 | 1.18% | 3.55% | 5.54% | Q2 2020 | Q4 2021 | 7 |
| CLVS | CLOVIS ONCOLOGY INC | 7 | 7 | 1.55% | 2.99% | 5.02% | Q1 2017 | Q3 2018 | 7 |
| CNST | CONSTELLATION PHARMACE... | 7 | 7 | 1.19% | 2.44% | 5.05% | Q4 2019 | Q2 2021 | 7 |
| ATNX | ATHENEX INC | 7 | 7 | 0.07% | 1.64% | 3.15% | Q2 2019 | Q4 2020 | 7 |
| QURE | UNIQURE NV | 5 | 1 | 0.08% | 1.61% | 3.58% | Q1 2015 | Q3 2020 | 7 |
| TGTX | TG THERAPEUTICS INC | 5 | 2 | 0.27% | 1.52% | 3.55% | Q4 2017 | Q1 2020 | 7 |
| ALLO | ALLOGENE THERAPEUTICS INC | 7 | 7 | 0.74% | 1.12% | 1.66% | Q4 2018 | Q2 2020 | 7 |
| RARE | ULTRAGENYX PHARMACEUTI... | 7 | 7 | 0.30% | 0.58% | 0.88% | Q1 2022 | Q3 2023 | 7 |
| PTX | PERNIX THERAPEUTICS HO... | 6 | 6 | 1.42% | 4.43% | 7.22% | Q4 2014 | Q1 2016 | 6 |
| NBIX | NEUROCRINE BIOSCIENCES... | 5 | 1 | 1.28% | 3.85% | 5.59% | Q4 2015 | Q2 2017 | 6 |
| ONTY | ONCOTHYREON INC | 6 | 6 | 1.80% | 3.55% | 5.78% | Q4 2014 | Q1 2016 | 6 |
| KPTI | KARYOPHARM THERAPEUTIC... | 5 | 1 | 0.36% | 2.42% | 4.54% | Q1 2018 | Q3 2020 | 6 |
| RLMD | RELMADA THERAPEUTICS INC | 6 | 6 | 0.52% | 0.95% | 1.32% | Q1 2020 | Q2 2021 | 6 |
| ADAP | ADAPTIMMUNE THERAPEUTI... | 5 | 1 | 0.15% | 0.83% | 1.98% | Q2 2015 | Q2 2021 | 6 |
| PRAX | PRAXIS PRECISION MEDIC... | 6 | 6 | 0.40% | 0.66% | 1.18% | Q4 2020 | Q1 2022 | 6 |
| BMY | BRISTOL MYERS SQUIBB CO. | 4 | 1 | 1.81% | 4.03% | 7.28% | Q1 2016 | Q4 2017 | 5 |
| INNL | INNOCOLL AG | 5 | 5 | 0.65% | 1.32% | 2.00% | Q4 2014 | Q4 2015 | 5 |
| AXGT | AXOVANT SCIENCES LTD. | 3 | 2 | 0.24% | 1.23% | 1.91% | Q2 2015 | Q2 2017 | 5 |
| NK | NANTKWEST- INC | 5 | 5 | 0.10% | 1.14% | 3.04% | Q3 2015 | Q3 2016 | 5 |
| AVEO | AVEO PHARMACEUTICALS INC | 5 | 5 | 0.30% | 0.94% | 1.86% | Q1 2017 | Q1 2018 | 5 |
| CASC | CASCADIAN THERAPEUTICS... | 5 | 5 | 0.58% | 0.76% | 0.96% | Q4 2016 | Q4 2017 | 5 |
| CUE | CUE BIOPHARMA INC | 5 | 5 | 0.10% | 0.63% | 0.91% | Q4 2019 | Q4 2020 | 5 |
| VIVE | VIVEVE MEDICAL INC | 5 | 5 | 0.27% | 0.49% | 0.72% | Q1 2017 | Q1 2018 | 5 |
| CRVS | CORVUS PHARMACEUTICALS... | 5 | 5 | 0.24% | 0.47% | 0.78% | Q1 2016 | Q1 2017 | 5 |
| BDTX | BLACK DIAMOND THERAPEU... | 5 | 5 | 0.18% | 0.33% | 0.44% | Q1 2020 | Q1 2021 | 5 |
| RLAY | RELAY THERAPEUTICS INC | 3 | 2 | 0.13% | 0.25% | 0.36% | Q3 2020 | Q3 2022 | 5 |
| IMMU | IMMUNOMEDICS INC | 3 | 2 | 0.01% | 0.21% | 0.53% | Q2 2016 | Q4 2017 | 5 |
| FOLD | AMICUS THERAPEUTICS INC | 5 | 5 | 0.03% | 0.21% | 0.65% | Q1 2017 | Q1 2018 | 5 |
| AVXS | AVEXIS INC | 3 | 1 | 2.19% | 3.43% | 4.28% | Q1 2017 | Q1 2018 | 4 |
| AERI | AERIE PHARMACEUTICALS INC | 4 | 4 | 1.53% | 2.99% | 4.66% | Q3 2016 | Q2 2017 | 4 |
| IG | IGI LABORATORIES INC | 4 | 4 | 2.26% | 2.77% | 3.04% | Q4 2014 | Q3 2015 | 4 |
| BLCM | BELLICUM PHARMACEUTICA... | 3 | 1 | 0.20% | 2.35% | 4.22% | Q4 2014 | Q1 2017 | 4 |
| TNXP | TONIX PHARMACEUTICALS ... | 4 | 4 | 0.56% | 1.29% | 1.87% | Q1 2015 | Q4 2015 | 4 |
| AKBA | AKEBIA THERAPEUTICS INC | 4 | 4 | 0.54% | 1.20% | 1.75% | Q2 2016 | Q1 2017 | 4 |
| MRNS | MARINUS PHARMACEUTICAL... | 4 | 4 | 0.39% | 0.49% | 0.60% | Q4 2019 | Q3 2020 | 4 |
| ARWR | ARROWHEAD PHARMACEUTIC... | 2 | 2 | 0.17% | 0.35% | 0.75% | Q2 2018 | Q3 2023 | 4 |
| KOD | KODIAK SCIENCES INC | 4 | 4 | 0.18% | 0.27% | 0.38% | Q4 2018 | Q3 2019 | 4 |
| MRUS | MERUS N V | 3 | 1 | 0.16% | 0.20% | 0.24% | Q1 2021 | Q3 2023 | 4 |
| BCTG | BCTG ACQUISITION CORP | 4 | 4 | 0.12% | 0.15% | 0.16% | Q3 2020 | Q2 2021 | 4 |
| XBI | SPDR SERIES TRUST - S&... | 3 | 1 | 0.05% | 0.09% | 0.20% | Q1 2018 | Q1 2019 | 4 |
| ARRY | ARRAY BIOPHARMA INC | 4 | 4 | 0.01% | 0.06% | 0.12% | Q1 2017 | Q4 2017 | 4 |
| ALIMERA SCIENCES INC | 4 | 4 | 0.03% | 0.06% | 0.09% | Q4 2019 | Q3 2020 | 4 | |
| RCPT | RECEPTOS INC | 3 | 3 | 1.39% | 3.81% | 7.26% | Q4 2014 | Q2 2015 | 3 |
| VRTX | VERTEX PHARMACEUTICALS... | 3 | 3 | 1.89% | 3.29% | 5.20% | Q1 2021 | Q3 2021 | 3 |
| ECYT | ENDOCYTE INC | 3 | 3 | 2.47% | 3.27% | 4.32% | Q1 2018 | Q3 2018 | 3 |
| XBI | SPDR SERIES TRUST - S&... | 3 | 3 | 1.32% | 2.78% | 5.00% | Q4 2021 | Q2 2022 | 3 |
| SGEN | SEATTLE GENETICS INC | 3 | 3 | 1.34% | 2.70% | 3.61% | Q3 2016 | Q1 2017 | 3 |
| PBYI | PUMA BIOTECHNOLOGY INC | 3 | 3 | 2.36% | 2.49% | 2.68% | Q1 2018 | Q3 2018 | 3 |
| AEGR | AEGERION PHARMACEUTICA... | 3 | 3 | 0.40% | 1.93% | 2.85% | Q3 2015 | Q1 2016 | 3 |
| FLML | FLAMEL TECHNOLOGIES | 3 | 3 | 1.49% | 1.85% | 2.49% | Q4 2014 | Q2 2015 | 3 |
| EGLTQ | EGALET CORPORATION. | 3 | 3 | 0.56% | 1.24% | 1.64% | Q3 2015 | Q1 2016 | 3 |
| ALQA | ALLIQUA BIOMEDICAL INC | 3 | 3 | 0.62% | 0.83% | 1.16% | Q2 2015 | Q4 2015 | 3 |
| ESTA | ESTABLISHMENT LABS HOL... | 3 | 3 | 0.49% | 0.60% | 0.78% | Q3 2018 | Q1 2019 | 3 |
| HTBX | HEAT BIOLOGICS INC | 3 | 3 | 0.41% | 0.53% | 0.64% | Q1 2015 | Q3 2015 | 3 |
| OLMA | OLEMA PHARMACEUTICALS INC | 3 | 3 | 0.42% | 0.49% | 0.61% | Q4 2020 | Q2 2021 | 3 |
| AMYLYX PHARMACEUTICALS... | 3 | 3 | 0.21% | 0.30% | 0.35% | Q3 2022 | Q1 2023 | 3 | |
| RCKT | ROCKET PHARMACEUTICALS... | 2 | 1 | 0.14% | 0.23% | 0.40% | Q2 2019 | Q3 2023 | 3 |
| VRCA | VERRICA PHARMACEUTICAL... | 3 | 3 | 0.18% | 0.22% | 0.26% | Q1 2023 | Q3 2023 | 3 |
| RACA | THERAPEUTICS ACQUISITI... | 3 | 3 | 0.18% | 0.21% | 0.24% | Q3 2020 | Q1 2021 | 3 |
| ONCS | ONCOSEC MEDICAL INC | 3 | 3 | 0.03% | 0.20% | 0.36% | Q1 2018 | Q3 2018 | 3 |
| SRPT | SAREPTA THERAPUTICS INC | 3 | 3 | 0.00% | 0.19% | 0.45% | Q2 2016 | Q4 2016 | 3 |
| MCRB | SERES THERAPEUTICS INC | 3 | 3 | 0.09% | 0.12% | 0.16% | Q1 2023 | Q3 2023 | 3 |
| CBIO | CATALYST BIOSCIENCES INC. | 3 | 3 | 0.04% | 0.07% | 0.10% | Q3 2015 | Q1 2016 | 3 |
| KITE | KITE PHARMA INC | 2 | 2 | 6.93% | 8.75% | 10.56% | Q2 2017 | Q3 2017 | 2 |
| CPXX | CELATOR PHARMACEUTICAL... | 2 | 2 | 5.45% | 6.50% | 7.54% | Q1 2016 | Q2 2016 | 2 |
| TARO | TARO PHARMACEUTICAL INDUS | 2 | 2 | 2.91% | 5.66% | 8.41% | Q4 2014 | Q1 2015 | 2 |
| EBS | EMERGENT BIOSOLUTIONS INC | 2 | 2 | 3.65% | 4.87% | 6.10% | Q4 2014 | Q1 2015 | 2 |
| MDVN | MEDIVATION INC | 2 | 2 | 3.75% | 4.04% | 4.34% | Q1 2016 | Q2 2016 | 2 |
| GILD | GILEAD SCIENCES INC | 2 | 2 | 2.01% | 3.82% | 5.62% | Q1 2016 | Q2 2016 | 2 |
| SPPI | SPECTRUM PHARMACEUTICA... | 1 | 1 | 2.04% | 2.40% | 2.76% | Q3 2015 | Q2 2018 | 2 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 1 | 1 | 1.56% | 1.92% | 2.28% | Q4 2014 | Q1 2018 | 2 |
| RXDX | IGNYTA INC. | 2 | 2 | 0.77% | 1.59% | 2.42% | Q4 2014 | Q1 2015 | 2 |
| STML | STEMLINE THERAPEUTICS INC | 1 | 1 | 0.38% | 1.51% | 2.64% | Q1 2015 | Q1 2018 | 2 |
| MOONLAKE IMMUNOTHERAPE... | 2 | 2 | 1.19% | 1.49% | 1.78% | Q2 2023 | Q3 2023 | 2 | |
| AZN | ASTRAZENECA PLC | 2 | 2 | 1.25% | 1.47% | 1.69% | Q4 2017 | Q1 2018 | 2 |
| EXELIXIS INC EXEL 2019... | 2 | 2 | 1.24% | 1.43% | 1.62% | Q4 2014 | Q1 2015 | 2 | |
| CASC | CASCADIAN THERAPEUTICS... | 2 | 2 | 1.20% | 1.41% | 1.62% | Q2 2016 | Q3 2016 | 2 |
| SGMO | SANGAMO THERAPEUTICS INC | 1 | 1 | 0.89% | 1.18% | 1.47% | Q1 2015 | Q2 2017 | 2 |
| BIOL | BIOLASE INC | 2 | 2 | 0.54% | 0.97% | 1.40% | Q4 2014 | Q1 2015 | 2 |
| HRTX | HERON THERAPEUTICS INC | 1 | 1 | 0.45% | 0.87% | 1.29% | Q4 2014 | Q2 2015 | 2 |
| ROIVANT SCIENCES LTD | 2 | 2 | 0.79% | 0.82% | 0.85% | Q2 2023 | Q3 2023 | 2 | |
| CBIO | CATALYST BIOSCIENCES INC | 2 | 2 | 0.35% | 0.81% | 1.26% | Q4 2017 | Q1 2018 | 2 |
| TVTX | TRAVERE THERAPEUTICS INC | 2 | 2 | 0.54% | 0.69% | 0.84% | Q4 2020 | Q1 2021 | 2 |
| AUPH | AURINIA PHARMACEUTICAL... | 2 | 2 | 0.54% | 0.69% | 0.84% | Q1 2020 | Q2 2020 | 2 |
| IWM | ISHARES RUSSELL 2000 ETF | 1 | 1 | 0.00% | 0.65% | 1.29% | Q3 2015 | Q2 2019 | 2 |
| SESN | SESEN BIO INC | 2 | 2 | 0.51% | 0.59% | 0.67% | Q2 2018 | Q3 2018 | 2 |
| INNL | INNOCOLL HOLDINGS PLC | 2 | 2 | 0.48% | 0.52% | 0.57% | Q2 2016 | Q3 2016 | 2 |
| TRGT | TARGACEPT INC | 2 | 2 | 0.45% | 0.49% | 0.53% | Q1 2015 | Q2 2015 | 2 |
| BIIB | BIOGEN INC | 1 | 1 | 0.37% | 0.44% | 0.50% | Q2 2015 | Q3 2021 | 2 |
| RTRX | RETROPHIN INC | 2 | 2 | 0.35% | 0.39% | 0.42% | Q2 2020 | Q3 2020 | 2 |
| YMAB | Y MABS THERAPEUTICS INC | 2 | 2 | 0.38% | 0.38% | 0.38% | Q3 2018 | Q4 2018 | 2 |
| PTI | PROTEOSTASIS THERAPEUT... | 1 | 1 | 0.25% | 0.37% | 0.49% | Q3 2016 | Q4 2018 | 2 |
| DBVT | DBV TECHNOLOGIES SA | 1 | 1 | 0.06% | 0.35% | 0.64% | Q3 2017 | Q3 2018 | 2 |
| JNCE | JOUNCE THERAPEUTICS INC | 1 | 1 | 0.10% | 0.33% | 0.56% | Q1 2018 | Q1 2021 | 2 |
| ACER | ACER THERAPEUTICS INC | 2 | 2 | 0.18% | 0.29% | 0.40% | Q3 2018 | Q4 2018 | 2 |
| VRAY | VIEWRAY INC | 2 | 2 | 0.19% | 0.28% | 0.38% | Q4 2017 | Q1 2018 | 2 |
| RVMD | REVOLUTION MEDICINES INC | 2 | 2 | 0.19% | 0.26% | 0.33% | Q1 2020 | Q2 2020 | 2 |
| SPDR SERIES TRUST - S&... | 1 | 1 | 0.21% | 0.22% | 0.23% | Q2 2015 | Q1 2016 | 2 | |
| ITOS | ITEOS THERAPEUTICS INC | 2 | 2 | 0.16% | 0.21% | 0.27% | Q3 2020 | Q4 2020 | 2 |
| IKNA | IKENA ONCOLOGY INC | 2 | 2 | 0.11% | 0.13% | 0.15% | Q2 2023 | Q3 2023 | 2 |
| AMTI | APPLIED MOLECULAR TRAN... | 2 | 2 | 0.06% | 0.10% | 0.14% | Q1 2022 | Q2 2022 | 2 |
| OVAS | OVASCIENCE INC | 2 | 2 | 0.06% | 0.09% | 0.12% | Q2 2017 | Q3 2017 | 2 |
| AGEN | AGENUS INC | 2 | 2 | 0.01% | 0.07% | 0.14% | Q3 2016 | Q4 2016 | 2 |
| IOVA | IOVANCE BIOTHERAPEUTIC... | 1 | 1 | 0.02% | 0.06% | 0.10% | Q1 2020 | Q3 2021 | 2 |
| ACAD | ACADIA PHARMACEUTICALS... | 1 | 1 | 0.02% | 0.05% | 0.08% | Q4 2016 | Q1 2018 | 2 |
| XBI | SPDR SERIES TRUST - S&... | 1 | 1 | 0.00% | 0.04% | 0.09% | Q4 2018 | Q1 2023 | 2 |
| APLS | APELLIS PHARMACEUTICAL... | 2 | 2 | 0.02% | 0.04% | 0.06% | Q2 2021 | Q3 2021 | 2 |
| CLVS | CLOVIS ONCOLOGY INC | 1 | 1 | 0.02% | 0.02% | 0.03% | Q1 2017 | Q4 2017 | 2 |
| OTLK | OUTLOOK THERAPEUTICS INC | 2 | 2 | 0.02% | 0.02% | 0.03% | Q4 2018 | Q1 2019 | 2 |
| TALS | TALARIS THERAPEUTICS INC | 2 | 2 | 0.02% | 0.02% | 0.02% | Q2 2023 | Q3 2023 | 2 |
| QQQ | INVESCO QQQ TRUST | 1 | 1 | 0.01% | 0.01% | 0.02% | Q3 2018 | Q3 2023 | 2 |
| ISh RUSSELL 2000 ETF | 2 | 2 | 0.00% | 0.01% | 0.02% | Q1 2016 | Q2 2016 | 2 | |
| BMRN | BIOMARIN PHARMACEUTICA... | 2 | 2 | 0.01% | 0.01% | 0.01% | Q4 2017 | Q1 2018 | 2 |
| MGNX | MACROGENICS INC | 2 | 2 | 0.00% | 0.00% | 0.00% | Q4 2017 | Q1 2018 | 2 |
| CELGENE CORP. | 1 | 1 | 6.58% | 6.58% | 6.58% | Q1 2015 | Q1 2015 | 1 | |
| ASCENDIS PHARMA | 1 | 1 | 4.23% | 4.23% | 4.23% | Q1 2021 | Q1 2021 | 1 | |
| ALXN | ALEXION PHARMACEUTICAL... | 1 | 1 | 4.20% | 4.20% | 4.20% | Q4 2016 | Q4 2016 | 1 |
| MACROGENICS INC. | 1 | 1 | 3.86% | 3.86% | 3.86% | Q4 2014 | Q4 2014 | 1 | |
| GWPH | GW PHARMACEUTICALS PLC | 1 | 1 | 3.11% | 3.11% | 3.11% | Q3 2016 | Q3 2016 | 1 |
| ANAC | ANACOR PHARMACEUTICALS... | 1 | 1 | 3.11% | 3.11% | 3.11% | Q1 2016 | Q1 2016 | 1 |
| LOXO | LOXO ONCOLOGY INC | 1 | 1 | 2.72% | 2.72% | 2.72% | Q4 2018 | Q4 2018 | 1 |
| CELG | CELGENE CORP. | 1 | 1 | 2.66% | 2.66% | 2.66% | Q4 2014 | Q4 2014 | 1 |
| ARWR | ARROWHEAD RESEARCH - CORP | 1 | 1 | 2.62% | 2.62% | 2.62% | Q4 2014 | Q4 2014 | 1 |
| RLYP | RELYPSA INC | 1 | 1 | 2.52% | 2.52% | 2.52% | Q2 2016 | Q2 2016 | 1 |
| CLDX | CELLDEX THERAPEUTICS INC | 1 | 1 | 2.45% | 2.45% | 2.45% | Q2 2015 | Q2 2015 | 1 |
| ARMO | ARMO BIOSCIENCES INC | 1 | 1 | 2.16% | 2.16% | 2.16% | Q1 2018 | Q1 2018 | 1 |
| VKTX | VIKING THERAPEUTICS INC | 1 | 1 | 1.63% | 1.63% | 1.63% | Q2 2018 | Q2 2018 | 1 |
| AGIO | AGIOS PHARMACEUTICALS INC | 1 | 1 | 1.39% | 1.39% | 1.39% | Q3 2016 | Q3 2016 | 1 |
| NVAX | NOVAVAX INC | 1 | 1 | 1.20% | 1.20% | 1.20% | Q4 2014 | Q4 2014 | 1 |
| CYTK | CYTOKINETICS INC. | 1 | 1 | 1.06% | 1.06% | 1.06% | Q2 2016 | Q2 2016 | 1 |
| SAGE | SAGE THERAPEUTICS INC | 1 | 1 | 0.97% | 0.97% | 0.97% | Q1 2020 | Q1 2020 | 1 |
| CCXI | CHEMOCENTRYX - INC | 1 | 1 | 0.94% | 0.94% | 0.94% | Q1 2015 | Q1 2015 | 1 |
| TXMD | THERAPEUTICS MD INC | 1 | 1 | 0.91% | 0.91% | 0.91% | Q1 2015 | Q1 2015 | 1 |
| CNDO | CORONADO BIOSCIENCES INC | 1 | 1 | 0.89% | 0.89% | 0.89% | Q1 2015 | Q1 2015 | 1 |
| TROV | TROVAGENE INC | 1 | 1 | 0.85% | 0.85% | 0.85% | Q1 2015 | Q1 2015 | 1 |
| BPMC | BLUEPRINT MEDICINES CORP | 1 | 1 | 0.84% | 0.84% | 0.84% | Q1 2017 | Q1 2017 | 1 |
| AXDX | ACCELERATE DIAGNOSTICS... | 1 | 1 | 0.84% | 0.84% | 0.84% | Q4 2015 | Q4 2015 | 1 |
| STRUCTURE THERAPEUTICS... | 1 | 1 | 0.79% | 0.79% | 0.79% | Q3 2023 | Q3 2023 | 1 | |
| FWP | FORWARD PHARMA A/S-ADR | 1 | 1 | 0.71% | 0.71% | 0.71% | Q4 2014 | Q4 2014 | 1 |
| XNCR | XENCOR INC | 1 | 1 | 0.66% | 0.66% | 0.66% | Q4 2016 | Q4 2016 | 1 |
| NVRO | NEVRO CORP | 1 | 1 | 0.47% | 0.47% | 0.47% | Q2 2017 | Q2 2017 | 1 |
| AKRO | AKERO THERAPEUTICS ORD | 1 | 1 | 0.44% | 0.44% | 0.44% | Q3 2023 | Q3 2023 | 1 |
| NLNK | NEWLINK GENETICS CORP | 1 | 1 | 0.42% | 0.42% | 0.42% | Q4 2017 | Q4 2017 | 1 |
| BOTA | BIOTA PHARMACEUTICALS-... | 1 | 1 | 0.39% | 0.39% | 0.39% | Q4 2014 | Q4 2014 | 1 |
| ALT | ALTIMMUNE INC | 1 | 1 | 0.38% | 0.38% | 0.38% | Q3 2020 | Q3 2020 | 1 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 1 | 1 | 0.33% | 0.33% | 0.33% | Q2 2019 | Q2 2019 | 1 |
| CERE | CEREVEL THERAPEUTICS H... | 1 | 1 | 0.32% | 0.32% | 0.32% | Q3 2023 | Q3 2023 | 1 |
| INCY | INCYTE CORP | 1 | 1 | 0.31% | 0.31% | 0.31% | Q4 2017 | Q4 2017 | 1 |
| CRSP | CRISPR THERAPEUTICS AG | 1 | 1 | 0.30% | 0.30% | 0.30% | Q3 2018 | Q3 2018 | 1 |
| RAPT | RAPT THERAPEUTICS INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2020 | Q3 2020 | 1 |
| IMGN | IMMUNOGEN INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q1 2020 | Q1 2020 | 1 |
| VSAR | VERSARTIS INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q3 2016 | Q3 2016 | 1 |
| CNTA | CENTESSA PHARMACEUTICA... | 1 | 1 | 0.19% | 0.19% | 0.19% | Q2 2021 | Q2 2021 | 1 |
| TSHA | TAYSHA GENE THERAPIES INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q3 2023 | Q3 2023 | 1 |
| TNDM | TANDEM DIABETES CARE INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q1 2018 | Q1 2018 | 1 |
| SPDR S&P 500 ETF | 1 | 1 | 0.18% | 0.18% | 0.18% | Q2 2017 | Q2 2017 | 1 | |
| OMED | ONCOMED PHARMACEUTICAL... | 1 | 1 | 0.17% | 0.17% | 0.17% | Q3 2016 | Q3 2016 | 1 |
| DOVA | DOVA PHARMACEUTICALS INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q1 2018 | Q1 2018 | 1 |
| TPTX | TURNING POINT THERAPEU... | 1 | 1 | 0.16% | 0.16% | 0.16% | Q3 2019 | Q3 2019 | 1 |
| DCPH | DECIPHERA PHARMACEUTIC... | 1 | 1 | 0.15% | 0.15% | 0.15% | Q4 2019 | Q4 2019 | 1 |
| ARPO | AERPIO PHARMACEUTICALS... | 1 | 1 | 0.13% | 0.13% | 0.13% | Q2 2021 | Q2 2021 | 1 |
| CEMP | CEMPRA INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q3 2016 | Q3 2016 | 1 |
| AVRO | AVROBIO INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q2 2018 | Q2 2018 | 1 |
| PRNB | PRINCIPIA BIOPHARMA INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q3 2018 | Q3 2018 | 1 |
| CRDF | CARDIFF ONCOLOGY INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2020 | Q2 2020 | 1 |
| SLDB | SOLID BIOSCIENCES INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q1 2018 | Q1 2018 | 1 |
| BCAB | BIOATLA INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2022 | Q3 2022 | 1 |
| GBT | GLOBAL BLOOD THERAPEUT... | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2018 | Q1 2018 | 1 |
| RCPT | RECEPTOS INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q4 2014 | Q4 2014 | 1 |
| DRNA | DICERNA PHARMACEUTICAL... | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2016 | Q3 2016 | 1 |
| HRTX | HERON THERAPEUTICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2015 | Q3 2015 | 1 |
| SPY | SPDR S&P 500 ETF | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2017 | Q3 2017 | 1 |
| KITE | KITE PHARMA INC. | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2015 | Q3 2015 | 1 |
| ISEE | IVERIC BIO INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2023 | Q1 2023 | 1 |
| ALNY | ALNYLAM PHARMACEUTICAL... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2021 | Q2 2021 | 1 |
| XON | INTREXON CORP. | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2016 | Q1 2016 | 1 |
| MDCO | MEDICINES CO | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2017 | Q2 2017 | 1 |
| SGEN | SEATTLE GENETICS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2019 | Q4 2019 | 1 |
| CBSTZ | CUBIST PHARMA-RTS | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2014 | Q4 2014 | 1 |
| GLPG | GALAPAGOS NV | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2021 | Q1 2021 | 1 |
| EXAS | EXACT SCIENCES CORP. | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2014 | Q4 2014 | 1 |
| AEGLEA BIOTHERAPEUTICS... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2023 | Q3 2023 | 1 | |
| AGLE | AEGLEA BIOTHERAPEUTICS... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2023 | Q2 2023 | 1 |
| XLRN | ACCELERON PHARMA INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2021 | Q3 2021 | 1 |
| NBIX | NEUROCRINE BIOSCIENCES... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2018 | Q4 2018 | 1 |
| ADAP | ADAPTIMMUNE THERAPEUTI... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2020 | Q2 2020 | 1 |
| AMRN | AMARIN CORP PLC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2020 | Q1 2020 | 1 |
| NKTR | NEKTAR THERAPEUTICS | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2020 | Q4 2020 | 1 |
Download | |||||||||
The securities at the top of the list , including AMICUS THERAPEUTICS INC, MIRATI THERAPEUTICS INC., and BIOMARIN PHARMACEUTICAL INC, are the highest-conviction holdings of Avoro Capital Advisors LLC.
The conviction is calculated by counting the number of quarters a security has been reported by Avoro Capital Advisors LLC. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Avoro Capital Advisors LLC owns currently or has owned in the past.